Best of JSCAI

Introduction

Sandeep Nathan, M.D., FSCAI

Peripheral: Evaluation of a Drug-Eluting Resorbable Scaffold in Infrapopliteal Arteries: Design Methodology for the LIFE-BTK Trial

Sahil A. Parikh, MD, FSCAI

Congenital: Global Perspective on PDA Management in the Extremely Premature: Shifting Trend Towards Transcatheter PDA Closure

Shyam K. Sathanandam, M.D., FSCAI

Coronary: Long-term Incidence of Myocardial Infarction and Death After CABG and PCI for Isolated Left Anterior Descending Artery Disease: A meta-analysis of randomized controlled trials

Megha Prasad, M.D.

Structural: Predictors of Residual Severe Tricuspid Regurgitation After Transcatheter Mitral Valve Repair

Craig Basman, MD, FACC, FSCAI

Featured Abstract Stage: Acute Coronary Syndromes and MI

Prognostic impact of blood glucose level in patients undergoing PCI

James Wheeler Johnson, MD

Impact of Obesity on In-hospital Post Percutaneous Coronary Intervention Outcomes in Otherwise Metabolically Healthy Patients with Acute Myocardial Infarction: A Propensity Matched Analysis Using National Inpatient Sample, 2020

Adhvithi Pingili, MBBS

Influence of Hospital Location on Outcomes in ST-Segment Myocardial Infarction Among Patients Hospitalized for Non-cardiac Indications

Peter Drossopoulos, BS

Association of Revascularization with Risk of Ventricular Arrhythmias in Patients with Chronic Total Occlusions

Simrat Dhaliwal, MD

Featured Abstract Stage: Complex PCI & Restenosis and Left Main & Multi-Vessel Interventions

Mechanisms of increasing arterial compliance by intravascular lithotripsy

Aleksandra B Gruslova, PhD

Gender Differences in Procedural Complications of Atherectomy

Christopher D Janish, M.D.

Safety and Outcomes of Ultra-Low Contrast Percutaneous Coronary Intervention in Patients with Chronic Kidney Disease: A Single Center Experience

Richard Sekerak

Five Years Trend in Readmission and Outcome of CTO-PCI in the United States

Olayiwola Bolaji, MD, MSc

Featured Abstract Stage: Peripheral Vascular Disease

Cost-Effectiveness of Renal Denervation for Uncontrolled Hypertension in the Presence of Antihypertensive Drugs: an Analysis for the U.S. Based on 6-Month Primary Results from the SPYRAL HTN-ON MED Randomized Trial

David E. Kandzari, M.D., FSCAI

Same-Day Discharge after Balloon Pulmonary Artery Angioplasty for Chronic Thromboembolic Pulmonary Hypertension

Jeff P Chidester, MD

Traditional Measures Do Not Predict Cardiogenic Shock in Submassive Pulmonary Embolism

Parth Shah, DO

Pooled, 6-month Safety and Efficacy Results Using the Symplicity Spyral Radiofrequency Renal Denervation Catheter

Eric Secemsky, MD, MSc, FSCAI

Featured Abstract Stage: Quality Improvement

Comparing Same-Day Discharge Rates Following Elective PCI Before Versus After COVID-19 and its Impact on Thirty-Day Complications: A Single-Center Analysis

Katarina Forsthoefel

Educational Experience of Interventional Cardiology Fellows in the United States and Canada

Baha Simsek, MD

Impact of a Novel Bleeding Reduction Protocol on Bleeding and Vascular Complications post-TAVR

Qabas Elkurwi, MD

Does it Matter if a Facility has On Site Surgery?

Bonnie H. Weiner, M.D. MSEC MBA, MSCAI

Featured Abstract Stage: Structural Heart Disease

Full-Body Embolic Protection During Transcatheter Aortic Valve Replacement: the Protect the Head-to-Head Study, A Pivotal, Randomized Study Comparing the Emboliner Embolic Protection Catheter to the Sentinel CPS

Alexandra J. Lansky, M.D., MSCAI

Multi-center Clinical Outcomes of a No-Implant Interatrial Shunt for Heart Failure with Preserved and Reduced Ejection Fraction: Six-month Outcomes from the ALLEVIATE-HF Feasibility Program

Molly Szerlip, M.D., FSCAI

TAVR in End-Stage Renal Disease Patients: Long-term Outcomes, Structural Valve Degeneration and need for Aortic Valve Reintervention

Samuel Gregerson

Impact of Baseline Tricuspid Regurgitation on Health Status and Clinical Outcomes After Transcatheter Edge-to-Edge Repair of the Mitral Valve: Insights from the STS/ACC TVT Registry

Yasser Sammour, MD, MSc

Featured Clinical Research: Part 1

Real-world evaluation of the feasibility and quality of PCI guidance using Dynamic Coronary Roadmap: A secondary analysis of the DCR4Contrast Multicenter, International Randomized Control Trial.

John C. Messenger, M.D., FSCAI

Distal versus Proximal Radial Artery Access for Cardiac Catheterization and Intervention: 1-year results of The DIPRA study

Karim Al-Azizi, M.D., FSCAI

Clinical Outcomes of the XIENCE Skypoint 48mm Drug-Eluting Stent in Long Coronary Artery Lesions: Primary Endpoint Data from the SPIRIT 48 Trial

Ki E Park, M.D., FSCAI

First-in-human experience with a novel (low profile, high flow) percutaneous ventricular assist device

Gagan Singh, M.D., FSCAI

Featured Clinical Research: Part 2

Long-term Outcomes following Large-Bore Thrombectomy with the FlowTriever System for the Treatment of Pulmonary Embolism from the Full 800-Patient US Cohort of the FLASH Registry

Sameer J. Khandhar, M.D., FSCAI

Contextualizing the BEST-CLI Trial Results in Clinical Practice

Eric Secemsky, MD, MSc, FSCAI

Development & Baseline Characteristics of a 1.13M-patient longitudinal cohort to assess CLTI quality of care

Alexander Craig Fanaroff, MD, MHS

Performance and Use of the Evolut FX Transcatheter Aortic Valve System: Updated Results from the Evolut FX Limited Market Release Clinical Survey

Tanvir K. Bajwa, M.D., FSCAI

Repeated coronary revascularization in high-risk patients treated with ticagrelor monotherapy after PCI: Insights from the randomized TWILIGHT trial

Usman Baber, M.D.

Predictive value of the Thrombotic Risk Criteria of the 2020 ESC guidelines for NSTE-ACS: validation in a large PCI registry.

George D. Dangas, M.D., Ph.D., MSCAI

Core-laboratory Angiographic Characteristics and Mortality of Patients with STEMI and COVID-19: Insights from the NACMI Registry

Payam Dehghani, MD

SCAI/ACC Joint Session

The ISCHEMIA Trial: An Interventionalist Viewpoint

Jacqueline E Tamis-Holland, M.D., FSCAI

Angiographic Quantitative Flow Ratio-Guided Coronary Intervention

Nadia R. Sutton, M.D., M.P.H., FSCAI

PCI of Left Main disease: What Insights can We Garner from the AHA/ACC 2021 Coronary Revascularization Guidelines?

Wayne B. Batchelor, M.D., FSCAI

The FLAVOUR Trial: IVUS or FFR to Guided PCI

William F. Fearon, M.D., FSCAI

SCAI Early Career Research Grant Symposium

Site Variability in use of Intra-coronary Imaging Guidance to Optimize Percutaneous Coronary Intervention

Chetan P Huded, M.D. M.Sc, FSCAI

Racial, Socioeconomic, and Geographic Disparities in the Management of Peripheral Artery Disease and Critical Limb Ischemia

Alexander Craig Fanaroff, MD, MHS

Use of Calcium Modification for Coronary Lesions After Introduction of Coronary IVL: National Trends and Hospital Variation

Neel Butala, M.D.

2023 Scientific Sessions

SCAI Science